Quantcast
Home > Quotes > DXR

Daxor Corporation Common Stock (DXR) Quote & Summary Data

DXR 
$6.72
*  
0.22
3.38%
Get DXR Alerts
*Delayed - data as of Dec. 13, 2018  -  Find a broker to begin trading DXR now
Exchange:AMEX
Industry: Health Care
Community Rating:
View:    DXR Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
Today's High / Low
$ 6.8167 / $ 6.40
Share Volume
14,273
90 Day Avg. Daily Volume
131,148
Previous Close
$ 6.50
52 Week High / Low
$ 21.66 / $ 3.4001
Market Cap
25,056,992
Annualized Dividend
$ .03
Ex Dividend Date
1/5/2018
Dividend Payment Date
1/12/2018
Current Yield
0.46 %
Beta
0.39

Intraday Chart

Shares Traded

Share Volume:
14,273
90 Day Avg. Daily Volume:
131,148

Trading Range

The current last sale of $6.72 is 97.64% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 6.8167 $ 21.66
 Low: $ 6.40 $ 3.4001

Company Description (as filed with the SEC)

Daxor Corporation is a medical device manufacturing company which provides additional biotechnology services. Daxor Corporation was originally incorporated in New York State as Iatric Corporation in May 1971 for cryobanking services and continues these services through its wholly-owned subsidiary, Scientific Medical Systems. In October 1971, the name Iatric Corporation was changed to Idant Corporation. In May 1973, the name Idant Corporation was changed to Daxor Corporation. Our principal executive offices are located at 350 Fifth Avenue, Suite 7120, New York, NY 10118. The "Investor Relations" section of our website provides free copies of our annual reports on Form 10-K, our quarterly reports on Form 10-Q, and any current reports on Form 8-K, Forms 3, 4 and 5. For the past 16 years, the Company's major focus has been the creation and development of the BVA-100 ® Blood Volume Analyzer, an instrument that rapidly and accurately measures human blood volume.  ... More ...  

Research Brokers before you trade

Want to trade FX?

Analyst Info